<?xml version="1.0"?>
<template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">
  <id>bf28cf56-1e91-40a3-9084-ccce6ffef1b3</id>
  <name>AHS OGN ADULT CDEP VTE Prophylaxis_Trauma Surgery Adult</name>
  <description>
    <lifecycle_state>Initial</lifecycle_state>
    <details>
      <purpose/>
      <use/>
      <misuse/>
    </details>
    <other_details>
      <item>
        <key>MetaDataSet:Sample Set </key>
        <value>Template metadata sample set </value>
      </item>
      <item>
        <key>Acknowledgements</key>
        <value/>
      </item>
      <item>
        <key>Business Process Level</key>
        <value/>
      </item>
      <item>
        <key>Care setting</key>
        <value/>
      </item>
      <item>
        <key>Client group</key>
        <value/>
      </item>
      <item>
        <key>Clinical Record Element</key>
        <value/>
      </item>
      <item>
        <key>Copyright</key>
        <value/>
      </item>
      <item>
        <key>Issues</key>
        <value/>
      </item>
      <item>
        <key>Owner</key>
        <value/>
      </item>
      <item>
        <key>Sign off</key>
        <value/>
      </item>
      <item>
        <key>Speciality</key>
        <value/>
      </item>
      <item>
        <key>User roles</key>
        <value/>
      </item>
    </other_details>
  </description>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">
    <items>
      <item>
        <key>Technical.ﻩ Technical Traceability</key>
        <value>{~AHSID~bf28cf56-1e91-40a3-9084-ccce6ffef1b3~NAME~AHS OGN ADULT CDEP VTE Prophylaxis_Trauma Surgery Adult}</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Clinical Decision Support&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;&lt;u&gt;&lt;strong&gt;Recommendation:&lt;/strong&gt;&lt;/u&gt;&amp;nbsp;Patients undergoing major surgery should receive prophylaxis at least during hospital stay and consider extended prophylaxis for those with additional risk factors.&lt;/p&gt;&lt;p&gt;Patients with trauma are at high risk for venous thromboembolism (VTE).&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width:0px&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;table cellpadding=&quot;1&quot; cellspacing=&quot;1&quot; border=&quot;1&quot; style=&quot;width:570px&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td&gt;Low Risk&lt;/td&gt;&lt;td style=&quot;width:482px&quot;&gt;Non-major surgery in patients less than 40 years old with no risk factors&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Moderate Risk&lt;/td&gt;&lt;td style=&quot;width:482px&quot;&gt;&lt;p&gt;1.&amp;nbsp;&amp;nbsp;&amp;nbsp; Non-major surgery with additional risk factors, or:&lt;/p&gt;&lt;p&gt;2.&amp;nbsp; Age 40-60 years old&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;High Risk&lt;/td&gt;&lt;td style=&quot;width:482px&quot;&gt;&lt;p&gt;1.&amp;nbsp;&amp;nbsp;&amp;nbsp; Age greater than 60 years old, or:&lt;/p&gt;&lt;p&gt;2.&amp;nbsp;&amp;nbsp;&amp;nbsp; 40-60 years old with additional risk factors&lt;/p&gt;&lt;p&gt;3.&amp;nbsp; Major surgery&amp;nbsp;in patients aged less than 40 with multiple risk factors&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Very High Risk&lt;/td&gt;&lt;td style=&quot;width:482px&quot;&gt;&lt;p&gt;1.&amp;nbsp;&amp;nbsp;&amp;nbsp; Major surgery in patients with multiple risk factors or:&lt;/p&gt;&lt;p&gt;2.&amp;nbsp;&amp;nbsp;&amp;nbsp; Any patient having hip or knee arthroplasty, or:&lt;/p&gt;&lt;p&gt;&lt;strong&gt;3.&amp;nbsp; Major trauma or spinal cord injury.&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&lt;u&gt;Risk Factors:&lt;/u&gt;&amp;nbsp;Spinal cord injury, lower extremity or pelvic fracture, major head injury, immobility, trauma with surgical procedures, blood transfusion, age greater than 60, injury severity score greater than 15, active COVID-19 infection&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;u&gt;&lt;strong&gt;Contraindications:&lt;/strong&gt;&lt;/u&gt;&lt;/p&gt;&lt;p&gt;Uncontrolled hypertension, Bleeding disorders (platelets less than 50 x 109/L), Recent intracranial or intraocular hemorrhage, Lumbar puncture within 24 hours, Active bleeding, Heparin-induced thrombocytopenia (HIT)&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;For patients on heparins, certain drugs can enhance bleeding tendency: acetylsalicylic acid (ASA) and other antiplatelet agents (e.g. clopidogrel, ticagrelor), and nonsteroidal anti-inflammatory drugs (NSAIDs) (particularly ketorolac). This is particularly relevant for patients with intrathecal catheters for analgesia where low molecular weight heparin (LMWH) or unfractionated heparin(UFH ) must NOT be used in conjunction with antiplatelet agents.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;u&gt;Caution –&amp;nbsp;Management of heparins with spinal punctures&lt;/u&gt;:&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;table cellpadding=&quot;1&quot; cellspacing=&quot;1&quot; border=&quot;1&quot; style=&quot;width:720px&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style=&quot;width:113px&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td style=&quot;width:133px&quot;&gt;&lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width:0px&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style=&quot;text-align:left; vertical-align:top&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td style=&quot;text-align:left; vertical-align:top&quot;&gt;&lt;p&gt;Time Before Puncture/Catheter Manipulation or Removal&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/td&gt;&lt;td style=&quot;width:172px&quot;&gt;Use of anticoagulant in Patients with Indwelling Neuraxial Catheter&lt;/td&gt;&lt;td style=&quot;width:111px&quot;&gt;&lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width:143px&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top; width:143px&quot;&gt;&lt;p&gt;Time After Puncture/Catheter Manipulation or Removal&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/td&gt;&lt;td style=&quot;width:186px&quot;&gt;Laboratory Tests&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top; width:113px&quot;&gt;Unfractionated Heparin (UFH) - for prophylaxis, less than 15,000 units /day&lt;/td&gt;&lt;td style=&quot;width:133px&quot;&gt;4 to 6 hours&lt;/td&gt;&lt;td style=&quot;width:172px&quot;&gt;Acceptable&lt;/td&gt;&lt;td style=&quot;width:111px&quot;&gt;&lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width:0px&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top&quot;&gt;&lt;p&gt;1 hour&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/td&gt;&lt;td style=&quot;width:186px&quot;&gt;Platelets during treatment for greater than 3 days&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style=&quot;vertical-align:top; width:113px&quot;&gt;Low Molecular Weight Heparin (LMWH) - for prophylaxis&lt;/td&gt;&lt;td style=&quot;width:133px&quot;&gt;12 hours&lt;/td&gt;&lt;td style=&quot;width:172px&quot;&gt;&lt;p&gt;For single daily dosing –&amp;nbsp;catheter acceptable&lt;/p&gt;&lt;p&gt;(remove catheter 12 hours prior to next dose of LMWH, and subsequent dose should be greater than 4 hours after removal)&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;For Twice daily dosing –&amp;nbsp;Do not maintain catheter&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;width:111px&quot;&gt;&lt;p&gt;First postoperative dose at least 12 hours after neuraxial puncture and at least 4 hours after removal&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;Subsequent dose at least 24 hours after the first dose&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;width:186px&quot;&gt;Platelets during treatment for greater than 3 days&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;u&gt;&lt;strong&gt;&amp;nbsp;Prophylaxis options for Neurological conditions&lt;/strong&gt;&lt;/u&gt;&lt;/p&gt;&lt;table cellpadding=&quot;1&quot; cellspacing=&quot;1&quot; border=&quot;1&quot; style=&quot;width:731px&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td&gt;&lt;strong&gt;Type of Neurological Condition&lt;/strong&gt;&lt;/td&gt;&lt;td style=&quot;width:228px&quot;&gt;Intermittent Device (Sequential Compression Device) Only&lt;/td&gt;&lt;td style=&quot;width:202px&quot;&gt;Pharmacoprophylaxis Only&lt;/td&gt;&lt;td style=&quot;width:210px&quot;&gt;Sequential Compression Device &amp;amp; Pharmacoprophylaxis&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;strong&gt;Intracerebral Hemorrhage (ICH)&lt;/strong&gt;&lt;/td&gt;&lt;td style=&quot;width:228px&quot;&gt;Less than or equal to 48 hours after ictus or ICH and prior to CT/MRI growth cessation&lt;/td&gt;&lt;td style=&quot;width:202px&quot;&gt;MOBILE IN BED and greater than or equal to 48 hours after CT/MRI confirmation of growth cessation of ICH&lt;/td&gt;&lt;td style=&quot;width:210px&quot;&gt;IMMOBILE and greater than or equal to 48 hours after confirmation of growth cessation of ICH&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;strong&gt;Post-Operative Neurosurgery&lt;/strong&gt;&lt;/td&gt;&lt;td style=&quot;width:228px&quot;&gt;Less than or equal to 24 hours post-operatively&lt;/td&gt;&lt;td style=&quot;width:202px&quot;&gt;NON-VENTILATED AND MOBILE IN BED greater than 24 hours post-operatively and LOW risk for venous thromboembolism (VTE)&lt;/td&gt;&lt;td style=&quot;width:210px&quot;&gt;VENTILATED OR IMMOBILE greater than 24 hours post-operatively and HIGH risk for VTE:&lt;br&gt;·&amp;nbsp;&amp;nbsp; &amp;nbsp;Brain malignancy&lt;br&gt;·&amp;nbsp;&amp;nbsp; &amp;nbsp;Elderly&lt;br&gt;·&amp;nbsp;&amp;nbsp; &amp;nbsp;Prolonged surgery&lt;br&gt;·&amp;nbsp;&amp;nbsp; &amp;nbsp;Pre-op or Post-op paresis&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;strong&gt;Spinal Cord Injury&lt;/strong&gt;&lt;/td&gt;&lt;td style=&quot;width:228px&quot;&gt;Less than or equal to 12 hours prior to planned surgery until 24 hour post-operatively&lt;/td&gt;&lt;td style=&quot;width:202px&quot;&gt;MOBILE IN BED and greater than 24 hours post-operatively&lt;/td&gt;&lt;td style=&quot;width:210px&quot;&gt;IMMOBILE and greater than 24 hours postoperatively&lt;br&gt;·&amp;nbsp;&amp;nbsp; &amp;nbsp;Complete vs. Incomplete&lt;br&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;strong&gt;Stroke&lt;/strong&gt;&lt;/td&gt;&lt;td style=&quot;width:228px&quot;&gt;Less than or equal to 24 hours of stroke irrespective of tPA therapy&lt;br&gt;·&amp;nbsp;&amp;nbsp; &amp;nbsp;Hemorrhagic transformation post-tPA&lt;br&gt;·&amp;nbsp;&amp;nbsp; &amp;nbsp;High risk for hemorrhagic transformation post-tPA&lt;/td&gt;&lt;td style=&quot;width:202px&quot;&gt;MOBILE IN BED and greater than 24 hours after stroke&lt;/td&gt;&lt;td style=&quot;width:210px&quot;&gt;IMMOBILE and greater than 24 hours after stroke&lt;br&gt;·&amp;nbsp;&amp;nbsp; &amp;nbsp;LARGE strokes, particularly in Diabetics&lt;br&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;strong&gt;Subarachnoid Hemorrhage&lt;/strong&gt;&lt;/td&gt;&lt;td style=&quot;width:228px&quot;&gt;Unsecured aneurysm&lt;br&gt;Secured aneurysm with high risk of ICH&lt;/td&gt;&lt;td style=&quot;width:202px&quot;&gt;MOBILE IN BED and secured aneurysm without ongoing high risk of ICH&lt;/td&gt;&lt;td style=&quot;width:210px&quot;&gt;IMMOBILE IN BED and secured aneurysm without ongoing high risk of ICH&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;strong&gt;Traumatic Brain Injury (TBI)&lt;/strong&gt;&lt;/td&gt;&lt;td style=&quot;width:228px&quot;&gt;Less than or equal to 24 hours following TBI&lt;/td&gt;&lt;td style=&quot;width:202px&quot;&gt;MOBILE IN BED and greater than 24 hours following TBI and CT/MRI confirmed stability of contusions/subdural hemorrhage (SDH)/ICH/Epidural hemorrhages&lt;/td&gt;&lt;td style=&quot;width:210px&quot;&gt;IMMOBILE IN BED and greater than 24 hours following TBI and CT/MRI confirmed stability of contusions/SDH/ICH/Epidural hemorrhages&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;strong&gt;Tumours of the Brain&lt;/strong&gt;&lt;/td&gt;&lt;td style=&quot;width:228px&quot;&gt;Un-resected hemorrhagic brain tumours including metastases from thyroid, renal cell, melanoma, choriocarcinoma&lt;/td&gt;&lt;td style=&quot;width:202px&quot;&gt;MOBILE IN BED and un-resected non-hemorrhagic tumours of the brain&lt;/td&gt;&lt;td style=&quot;width:210px&quot;&gt;IMMOBILE IN BED and un-resected non-hemorrhagic tumour of the brain&lt;br&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Clinical Decision Support&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;High Risk of Bleeding Contraindications&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;&amp;nbsp;When bleeding risk decreases, pharmacologic thromboprophylaxis should be substituted for or added to mechanical thromboprophylaxis&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;High Risk of Bleeding Contraindications&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;NR&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;High Risk VTE Prophylaxis&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;All patients with trauma are at high risk of VTE and should be considered for early initiation.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;High Risk VTE Prophylaxis&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Anticoagulants&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]">
    <items>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;OSQs with restrictors will display based on patient weight&lt;/p&gt;</value>
      </item>
      <item>
        <key>Transform.Clinical Notes</key>
        <value>&lt;p&gt;If the patient has a current weight, the correct dose of tinzaparin/enoxaparin according to dose banding will be selected. If not, prescriber will need to enter the dose according to the dose banding chart&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;High Risk VTE Prophylaxis&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Anticoagulants&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;If there is no weight documented on this patient. &amp;nbsp;Please close this order, document a weight, then re-order. OR, you may use the chart in the VTE Program to determine the dose.&lt;br&gt;&amp;nbsp;&lt;/p&gt;&lt;table border=&quot;1&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width:457px&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;Weight Band Patient Actual Body Weight (kg)&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Tinzaparin Dose (units)&lt;br&gt;Non-major trauma&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;width:120px&quot;&gt;&lt;p&gt;Enoxaparin Dose (mg)&lt;br&gt;Major trauma&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;Less than 30 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;2500 units once daily&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;width:120px&quot;&gt;&lt;p&gt;n/a&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;30 to 39.9 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;3500 units once daily&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;width:120px&quot;&gt;&lt;p&gt;n/a&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;40 to 100 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;4500 units once daily&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;width:120px&quot;&gt;&lt;p&gt;30 mg every 12 hours&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;100.1 to 120 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;8000 units once daily&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;width:120px&quot;&gt;&lt;p&gt;40 mg every 12 hours&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;120.1 to 150 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;10,000 units once daily&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;width:120px&quot;&gt;&lt;p&gt;40 mg every 12 hours&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;150.1 to 175 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;12,000 units once daily&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;width:120px&quot;&gt;&lt;p&gt;60 mg every 12 hours&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;175.1 to 200 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;14,000 units once daily&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;width:120px&quot;&gt;&lt;p&gt;60 mg every 12 hours&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;200.1 to 250 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;16,000 units once daily&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;width:120px&quot;&gt;&lt;p&gt;80 mg every 12 hours&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;Greater than 250 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;75 units/kg once daily&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;width:120px&quot;&gt;&lt;p&gt;0.4 mg/kg every 12 hours&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;High Risk VTE Prophylaxis&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Anticoagulants&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;tinzaparin subcutaneous; *** units, subcutaneous, daily, at bedtime&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;NR&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;High Risk VTE Prophylaxis&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Anticoagulants&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;enoxaparin (Noromby syringe/Redesca vial) injection (adult); *** mg, subcutaneous, every 12 hours, scheduled&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;NR&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;High Risk VTE Prophylaxis&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Anticoagulants&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;High Risk VTE Prophylaxis&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Anticoagulants&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;High Risk VTE Prophylaxis&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Renal Dysfunction Dosing&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;tinzaparin subcutaneous; (4,500 unit/0.45 mL injection syringe (adjust for weight less than 40 kg)), 4,500 units, subcutaneous, daily, at bedtime, Continue until discharge&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;NR&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;High Risk VTE Prophylaxis&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Renal Dysfunction Dosing&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;heparin injection for bolus - units, units/kg/dose; (If eGFR +/- Creatinine Clearance LESS than 20 mL/minute) 5,000 units, subcutaneous, every 12 hours, Continue until discharge&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;NR&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;High Risk VTE Prophylaxis&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Renal Dysfunction Dosing&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;High Risk VTE Prophylaxis&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Additional Therapy&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Consider selecting &lt;strong&gt;ONE &lt;/strong&gt;of the following additional therapy orders:&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;High Risk VTE Prophylaxis&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Additional Therapy&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Sequential Compression Device; Until Discontinued, Apply Bilateral, Recommended for highest risk patients as additional therapy.&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;NR&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;High Risk VTE Prophylaxis&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Additional Therapy&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;AntiEmbolism Stockings; Until Discontinued, Apply Bilateral&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;NR&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;High Risk VTE Prophylaxis&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Additional Therapy&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;High Risk VTE Prophylaxis&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;NR&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;High Risk - Extended Prophylaxis&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;NR&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;High Risk - Extended Prophylaxis&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Patient undergoing surgery for major trauma or spinal cord injury should be considered for extended prophylaxis with LMWH or UFH up to four weeks.&lt;br&gt;&amp;nbsp;&lt;br&gt;For patients undergoing extensive surgery select the tinzaparin order. Also consider selecting ONE of the patient care orders (Graduated Compression Stockings or Sequential Compression Device):&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;High Risk - Extended Prophylaxis&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Anticoagulants&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]">
    <items>
      <item>
        <key>Transform.Clinical Notes</key>
        <value>&lt;p&gt;If the patient has a current weight, the correct dose of tinzaparin/enoxaparin according to dose banding will be selected. If not, prescriber will need to enter the dose according to the dose banding chart&lt;/p&gt;</value>
      </item>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;OSQs with restrictors will display based on patient weight&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;High Risk - Extended Prophylaxis&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Anticoagulants&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;If there is no weight documented on this patient. &amp;nbsp;Please close this order, document a weight, then re-order. OR, you may use the chart in the VTE Program to determine the dose.&lt;br&gt;&amp;nbsp;&lt;/p&gt;&lt;table border=&quot;1&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&quot;width:457px&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;Weight Band Patient Actual Body Weight (kg)&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Tinzaparin Dose (units)&lt;br&gt;Non-major trauma&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;width:120px&quot;&gt;&lt;p&gt;Enoxaparin Dose (mg)&lt;br&gt;Major trauma&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;Less than 30 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;2500 units once daily&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;width:120px&quot;&gt;&lt;p&gt;n/a&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;30 to 39.9 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;3500 units once daily&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;width:120px&quot;&gt;&lt;p&gt;n/a&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;40 to 100 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;4500 units once daily&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;width:120px&quot;&gt;&lt;p&gt;30 mg every 12 hours&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;100.1 to 120 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;8000 units once daily&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;width:120px&quot;&gt;&lt;p&gt;40 mg every 12 hours&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;120.1 to 150 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;10,000 units once daily&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;width:120px&quot;&gt;&lt;p&gt;40 mg every 12 hours&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;150.1 to 175 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;12,000 units once daily&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;width:120px&quot;&gt;&lt;p&gt;60 mg every 12 hours&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;175.1 to 200 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;14,000 units once daily&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;width:120px&quot;&gt;&lt;p&gt;60 mg every 12 hours&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;200.1 to 250 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;16,000 units once daily&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;width:120px&quot;&gt;&lt;p&gt;80 mg every 12 hours&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;Greater than 250 kg&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;75 units/kg once daily&lt;/p&gt;&lt;/td&gt;&lt;td style=&quot;width:120px&quot;&gt;&lt;p&gt;0.4 mg/kg every 12 hours&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;High Risk - Extended Prophylaxis&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Anticoagulants&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;tinzaparin subcutaneous; *** units, subcutaneous, daily, at bedtime&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;NR&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;High Risk - Extended Prophylaxis&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Anticoagulants&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;enoxaparin (Noromby syringe/Redesca vial) injection (adult); *** mg, subcutaneous, every 12 hours, scheduled&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;NR&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;High Risk - Extended Prophylaxis&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Anticoagulants&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;High Risk - Extended Prophylaxis&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Renal Dysfunction Dosing&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;tinzaparin subcutaneous; (4,500 unit/0.45 mL injection syringe (adjust for weight less than 40 kg)), 4,500 units, subcutaneous, daily, at bedtime, Continue until discharge&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;NR&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;High Risk - Extended Prophylaxis&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Renal Dysfunction Dosing&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;heparin injection for bolus - units, units/kg/dose; (IF eGFR +/- Creatinine Clearance LESS than 20 mL/minute), 5,000 units, subcutaneous, every 12 hours, Continue until discharge&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;NR&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;High Risk - Extended Prophylaxis&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Renal Dysfunction Dosing&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;High Risk - Extended Prophylaxis&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patient Care&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Consider selecting ONE of the following additional therapy orders:&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;High Risk - Extended Prophylaxis&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Discharge Instructions/Follow Up&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;VTE prophylaxis on fondaparinux or low molecular weight heparin (LMWH) for 28 days.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;High Risk - Extended Prophylaxis&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Discharge Instructions/Follow Up&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Treatment Options&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Laboratory Investigations Routine&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Laboratory Investigations Repeating&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;&amp;nbsp;To monitor platelet count for heparin-induced thrombocytopenia (HIT) in heparin-exposed patients with risk of HIT greater than 1%.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Laboratory Investigations Repeating&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="VTE Prophylaxis - Trauma Surgery Adult">
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Clinical Decision Support">
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="fed492db-9a3c-4739-a42f-6ad38f1386f0" concept_name="NURCOM CDS Technical Item - Do Not Order [NURCDS1] IP Order" max="1" path="/items" name="CDS Technical Item - Do Not Order"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Treatment Options">
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="High Risk of Bleeding Contraindications">
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="528e44bc-af74-465f-a535-3a62f4bb1d0c" concept_name="NURINT Sequential Compression Device [NUR536] IP Order" max="1" path="/items" name="Sequential Compression Device; Apply, Until discontinued. For patients with a high risk of bleeding, use SCDs at least until the initial risk of bleeding decreases"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="df94fc61-7e8a-4890-8269-d3cea3b1064f" concept_name="NURINT AntiEmbolism Stockings [NUR560] IP Order" max="1" path="/items" name="AntiEmbolism Stockings; Apply, Bilateral, Until discontinued"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="High Risk VTE Prophylaxis">
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Anticoagulants">
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="VTE Prophylaxis">
            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="baa37fce-55b8-485d-9df4-c61cfa2db8b0" concept_name="PHARM tinzaparin injection Order" max="1" path="/items" name="tinzaparin subcutaneous; *** units, subcutaneous, daily, at bedtime"/>
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="8c50ffc8-0dbe-4b6c-a856-5e03ab6eb2fe" concept_name="PHARM enoxaparin injection Order" max="1" path="/items" name="enoxaparin (Noromby syringe/Redesca vial) injection (adult); *** mg, subcutaneous, every 12 hours, scheduled"/>
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
          </Item>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
        </Item>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Renal Dysfunction Dosing">
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="baa37fce-55b8-485d-9df4-c61cfa2db8b0" concept_name="PHARM tinzaparin injection Order" max="1" path="/items" name="tinzaparin subcutaneous; (4,500 unit/0.45 mL injection syringe (adjust for weight less than 40 kg)), 4,500 units, subcutaneous, daily, at bedtime, Continue until discharge"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="f6df7262-0810-4ee2-bb10-c315c36e987c" concept_name="PHARM heparin, preservative free injection Order" max="1" path="/items" name="heparin injection for bolus - units, units/kg/dose; (If eGFR +/- Creatinine Clearance LESS than 20 mL/minute) 5,000 units, subcutaneous, every 12 hours, Continue until discharge"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
        </Item>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Additional Therapy">
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="528e44bc-af74-465f-a535-3a62f4bb1d0c" concept_name="NURINT Sequential Compression Device [NUR536] IP Order" max="1" path="/items" name="Sequential Compression Device; Until Discontinued, Apply Bilateral, Recommended for highest risk patients as additional therapy."/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="df94fc61-7e8a-4890-8269-d3cea3b1064f" concept_name="NURINT AntiEmbolism Stockings [NUR560] IP Order" max="1" path="/items" name="AntiEmbolism Stockings; Until Discontinued, Apply Bilateral"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
        </Item>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="High Risk - Extended Prophylaxis">
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Anticoagulants">
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="VTE Prophylaxis">
            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="baa37fce-55b8-485d-9df4-c61cfa2db8b0" concept_name="PHARM tinzaparin injection Order" max="1" path="/items" name="tinzaparin subcutaneous; *** units, subcutaneous, daily, at bedtime"/>
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="8c50ffc8-0dbe-4b6c-a856-5e03ab6eb2fe" concept_name="PHARM enoxaparin injection Order" max="1" path="/items" name="enoxaparin (Noromby syringe/Redesca vial) injection (adult); *** mg, subcutaneous, every 12 hours, scheduled"/>
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
          </Item>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
        </Item>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Renal Dysfunction Dosing">
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="baa37fce-55b8-485d-9df4-c61cfa2db8b0" concept_name="PHARM tinzaparin injection Order" max="1" path="/items" name="tinzaparin subcutaneous; (4,500 unit/0.45 mL injection syringe (adjust for weight less than 40 kg)), 4,500 units, subcutaneous, daily, at bedtime, Continue until discharge"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="f6df7262-0810-4ee2-bb10-c315c36e987c" concept_name="PHARM heparin, preservative free injection Order" max="1" path="/items" name="heparin injection for bolus - units, units/kg/dose; (IF eGFR +/- Creatinine Clearance LESS than 20 mL/minute), 5,000 units, subcutaneous, every 12 hours, Continue until discharge"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
        </Item>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Patient Care">
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="528e44bc-af74-465f-a535-3a62f4bb1d0c" concept_name="NURINT Sequential Compression Device [NUR536] IP Order" max="1" path="/items" name="Sequential Compression Device; Until Discontinued, Apply Bilateral, Recommended for highest risk patients as additional therapy."/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="df94fc61-7e8a-4890-8269-d3cea3b1064f" concept_name="NURINT AntiEmbolism Stockings [NUR560] IP Order" max="1" path="/items" name="AntiEmbolism Stockings; Until Discontinued, Apply Bilateral"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
        </Item>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Discharge Instructions/Follow Up">
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="a4066b92-bf1d-46a8-9802-d8a62ee534a5" concept_name="NURAX Discharge Activity [NUR652] Order" max="1" path="/items" name="Discharge Activity; Medication Instructions, Continue with anticoagulation therapy for a total of 28 days."/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="07af740c-f7eb-4017-9aa2-c688f984867b" concept_name="NUREDU Patient Education [NUR593] Order" max="1" path="/items" name="Patient Education; Prior to discharge, Ensure patient has prescription and teaching provided on injection."/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
        </Item>
      </Item>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Laboratory Investigations Routine">
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d58f0c7d-30da-4d27-a82a-b42c8fae7c23" concept_name="LAB CBC No Differential [LAB294] Order" max="1" path="/items" name="CBC, No Differential; Once Routine, To provide baseline platelet count for patients receiving heparin"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Laboratory Investigations Repeating">
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d58f0c7d-30da-4d27-a82a-b42c8fae7c23" concept_name="LAB CBC No Differential [LAB294] Order" max="1" path="/items" name="CBC, No Differential; Every 3 days, for 5 occurrences"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
    </Item>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4e79ae6f-5402-4d96-b79f-68e943d8a4d2" concept_name="NURCOM Notify Most Responsible Health Practitioner (MRHP) [NUR183] IP Order" max="1" path="/items" name="Notify Most Responsible Health Practitioner (MRHP); Notify to reassess prophylaxis if platelets 100 x 10^9/L or less"/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
  </definition>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">
    <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">
    <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">
    <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1">
    <digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1">
    <digest id="MD5-CAM-1.0.1">A7EC4E4C870D8C3431B29F6514353416</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.freetextorderquestion.v1">
    <digest id="MD5-CAM-1.0.1">5DC6E2FC9E91ADD05E7C5B3E06F83D23</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.booleanorderquestion.v1">
    <digest id="MD5-CAM-1.0.1">56B5A2F2979B94F83C97E66B46679692</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.quantityorderquestion.v1">
    <digest id="MD5-CAM-1.0.1">22AFA84E6D7935A3623EDFA7C2EB6D65</digest>
  </integrity_checks>
</template>